InvestorsHub Logo
Followers 74
Posts 15841
Boards Moderated 0
Alias Born 04/26/2010

Re: Number sleven post# 372569

Tuesday, 03/08/2022 5:31:03 PM

Tuesday, March 08, 2022 5:31:03 PM

Post# of 425942
I agree with your assessment, although it's not exactly logical - the court declined to sever the claims filed against Hikma and HN, but he dismissed the claims against Hikma. Read the CC transcript - KM even says they are going to appeal the dismissal of Hikma. What's illogical is how can you dismiss Hikma w/o severing the claims? Only way that make sense is if there were zero overlapping claims. How the judge could dismiss Hikma just from reading briefs is beyond me - that means they had an overwhelming defense that they were not infringing - also points out the any attempt to connect this case to GSK/Teva were misguided, the behavior of Teva was obviously infringing, and Hikma was not that stupid.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News